In the last decade, the study of gut microbiota and its impact on human health has became a major area of research. This large microbial community, housed throughout the human gastrointestinal tract, performs many biological and metabolic functions and confers benefits to its host. Today, a number of intestinal or extra-digestive pathologies, such as obesity or IBS, are associated with an imbalance in the composition and function of intestinal microbiota so called “dysbiosis”. For technical, reproducibility, regulatory, ethical and cost reasons, in vitro gut models are an excellent complement to in vivo assays. However, to date, there is rare in vitro models of the colonic environment under diseased situation. To overcome this gap, we have recently developed an in vitro system reproducing the physicochemical and microbial parameters found in the colonic environment of obese patients.
Obese parameters vs healthy ones
Activity analysis
Composition analysis
=> Validated by in vivo data in humans
Obese M-ARCOL model can be used
Stéphanie BLANQUET-DIOT
Directrice Adjointe
UMR 454 MEDIS Microbiologie Environnement Digestif et Santé